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Abstract  28 
Action potential firing in hippocampal pyramidal neurons is regulated by generation of an 29 
afterhyperpolarization (AHP).  Three phases of AHP are recognised, with the fast AHP 30 
regulating action potential firing at the onset of a burst, and the medium and slow AHPs 31 
supressing action potential firing over 100s of milliseconds and seconds respectively.  32 
Activation of β-adrenergic receptors suppresses the slow AHP by a protein kinase A-33 
dependent pathway.  However, little is known regarding modulation of the medium AHP.  34 
Application of the selective β-adrenergic receptor agonist isoproterenol suppressed both the 35 
medium and slow AHPs evoked in rat CA1 hippocampal pyramidal neurons recorded from 36 
slices maintained in organotypic culture.  Suppression of the slow AHP was mimicked by 37 
intracellular application of cAMP, with the suppression of the medium AHP by isoproterenol 38 
still being evident in cAMP-dialysed cells.  Suppression of both the medium and slow AHPs 39 
was antagonised by the β-adrenergic receptor antagonist propranolol.  The effect of 40 
isoproterenol to suppress the medium AHP was mimicked by two β3-adrenergic receptor 41 
agonists: BRL37344 and SR58611A.  The medium AHP was mediated by activation of SK 42 
and deactivation of H channels at the resting membrane potential.  Suppression of the 43 
medium AHP by isoproterenol was reduced by pre-treating cells with the H-channel blocker 44 
ZD7288.  These data suggest that activation of β3-adrenergic receptors inhibits H-channels, 45 
which suppresses the medium AHP in CA1 hippocampal neurons by utilising a pathway that 46 
is independent of a rise of intracellular cAMP.  This finding highlights a potential new target 47 
in modulating H-channel activity, and thereby neuronal excitability.   48 
 49 
 50 
New & Noteworthy 51 
The noradrenergic input into the hippocampus is involved in modulating long-term synaptic 52 
plasticity and is implicated in learning and memory.  We demonstrate that activation of 53 
functional β3-adrenergic receptors suppresses the medium AHP in hippocampal pyramidal 54 
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neurons.  This finding provides an additional mechanism to increase action potential firing 55 
frequency, where neuronal excitability is likely to be crucial in cognition and memory.  56 
 57 
 58 
Introduction 59 
Action potential firing is regulated by the generation of an afterhyperpolarization (AHP) 60 
following a single or train of action potentials (Alger and Nicoll, 1980; Madison and Nicoll, 61 
1984; Alger and Williamson, 1988; Storm, 1990; Gu et al., 2005).  The AHP influences both 62 
the frequency and patterning of neuronal firing.  An increase in action potential firing is 63 
observed after pharmacologically inhibiting AHPs (Lancaster and Adams, 1986; Pedarzani 64 
and Storm, 1993; Stocker et al., 1999; Gu et al., 2005; Tombaugh et al., 2005), while a 65 
decrease in action potential firing results from potentiation of the AHP (Pedarzani et al., 66 
2005; Gu et al., 2008).  Hippocampal CA1 pyramidal neurons exhibit an AHP that has three 67 
main components, based on both kinetics and pharmacology.  The fast AHP results from 68 
activation of BK channels and regulates firing at the onset of a burst (Storm, 1989).  In 69 
contrast, the medium AHP regulates firing 50-200 ms after a burst of action potentials and 70 
the slow AHP affects firing over many seconds following a burst of action potentials (Storm, 71 
1989; Stocker, 2004; Gu et al., 2005; Vatanparast and Janahmadi, 2009; Chen et al., 2014).  72 
The medium AHP in hippocampal CA1 neurons is mediated by 3 different ion channel 73 
subtypes, small-conductance, calcium-activated K+ (SK) channels (Stocker et al., 1999; 74 
Bond et al., 2004; Church et al., 2014), voltage-dependent M-channels (KV7/KCNQ) (Gu et 75 
al., 2005; Tzingounis et al., 2007), and the hyperpolarization-activated cyclic nucleotide-76 
gated (HCN) channel (Gu et al., 2005; Kaczorowski, 2011).  There is still controversy 77 
regarding the channel(s) underlying the slow AHP in hippocampal pyramidal neurons, with 78 
the intermediate-conductance Ca2+-dependent K+ (IK) channel (King et al., 2015; Turner et 79 
al., 2016), voltage-dependent KV7 channel (Tzingounis et al., 2007), and ATPase-Na+/K+ 80 
pump (Gulledge et al., 2013) all been proposed to mediate this slow afterpotential. 81 
 82 
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The slow AHP is unusual in being suppressed by different monoamines, such as  83 
noradrenaline (Madison and Nicoll, 1982; Pedarzani and Storm, 1993), dopamine (Malenka 84 
and Nicoll, 1986), serotonin (Pedarzani and Storm, 1993), and histamine (Haas and Greene, 85 
1986; Pedarzani and Storm, 1993).  Monoamine neurotransmitters suppress the slow AHP 86 
by the canonical Gαs G-protein pathway, which results in the formation of cAMP by the 87 
stimulation of adenylate cyclase and subsequent activation of protein kinase A (Pedarzani 88 
and Storm, 1993).  For example, suppression of the slow AHP by noradrenaline is 89 
antagonised by the β-adrenergic receptor (βAR) antagonist propranolol (Madison and Nicoll, 90 
1982).  Immunohistochemistry has identified that β1- and β2-adrenergic receptors are 91 
expressed throughout the hippocampus, with both subtypes being located in both the soma 92 
and dendrites of CA1 pyramidal neurons (Guo and Li, 2007; Cox et al., 2008).  β3-93 
adrenergic receptor mRNA has also been identified in the rodent and human hippocampus 94 
(Rodriguez et al., 1995; Evans et al., 1996), albeit a lower expression than seen for β1 and 95 
β2 receptors (Evans et al., 1996; Claustre et al., 2008).  The functional role of the β3AR in 96 
the hippocampus is unclear; however β3AR agonists demonstrate anti-depressant and 97 
anxiolytic effects in rodents (Simiand et al., 1992; Consoli et al., 2007; Claustre et al., 2008; 98 
Tamburella et al., 2010; Tanyeri et al., 2013). 99 
 100 
In this study we show that non-selective pharmacological activation of β-adrenergic 101 
receptors suppressed both the medium and slow AHPs, an effect antagonised by 102 
propranolol.  The effect of β receptor activation on the slow AHP was occluded by 103 
intracellular dialysis of cAMP, whereas suppression of medium AHP persisted.  The medium 104 
AHP was generated by SK and HCN channels in CA1 neurons held at -75 mV, with the 105 
effect of isoproterenol reduced by prior block of HCN-mediated H-current.  Suppression of 106 
the medium AHP was mimicked by two different selective β3-adrenergic receptor agonists.  107 
These data suggest that the activation of β3-adrenergic receptors suppresses the medium 108 
AHP by inhibiting HCN channel activity using a cAMP-independent pathway.  These findings 109 
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illustrate an additional mechanism to modulate hippocampal neuron excitability utilising a 110 
novel pathway.  111 
  112 
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Materials and Methods 113 
Organotypic hippocampal slice cultures.  Organotypic slice cultures from the hippocampus 114 
were prepared from 18 to 20-day-old male Wistar rats as described previously (Stoppini et 115 
al., 1991).  Rats were killed by cervical dislocation in accordance with Schedule 1 of the UK 116 
home office guidelines set out in the Animals (Scientific Procedures) Act 1986.  All 117 
procedures were carried out in accordance with the UK Animal (Scientific Procedures) Act, 118 
1986, and EU Directive 2010/63/EU.  All experimental procedures were reviewed by the 119 
University of Bristol Ethical Review Group (reference: UB/12/006).  Brains were removed 120 
and horizontal brain slices (300 µM) were cut in ice-cold (~4 ˚C) sucrose-based cutting 121 
solution containing (in mM): 189 sucrose, 10 D-glucose, 26 NaHCO3, 3 KCL, 5 122 
MgSO4.7H2O, 0.1 CaCl2, 1.25 NaH2PO4, saturated with 95% O2 and 5% CO2 using a 123 
VT1000 S vibrating blade microtome (Leica Microsystems Ltd, Milton Keynes, UK).  After 124 
sectioning, hippocampal slices were transferred to a storage chamber filled with artificial 125 
cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl, 3 KCl, 24 NaHCO3, 1.25 126 
NaH2PO4.H2O, 1 MgSO4.7H2O, 2 CaCl2, 10 D-glucose saturated with 95% O2 and 5% CO2.  127 
Under aseptic conditions, slices were washed twice with culture media containing Minimum 128 
Essential Medium (Gibco) supplemented with (in mM): 50 NaHCO3, 75 HEPES, 0.437 129 
glutamine, 0.625 CaCl2, 1.25 MgSO4.7H2O, 0.425 ascorbic acid, 32 D-glucose, with 12.5% 130 
heat-inactivated horse serum, 1 mg/lL insulin, and 100 units/ml penicillin with 100 µg/ml 131 
streptomycin (pH 7.28 with NaOH, osmolarity ~ 320 mOsm).  Slices were washed a further 132 
two times in culture media without supplemented penicillin/streptomycin.  Slices were 133 
cultured on a porous (0.4 µM) membrane (Millicell inserts, Millipore) and maintained at 37˚C 134 
in 5% CO2 for 3 days before slices were used for electrophysiological recordings.  The 135 
characteristics of the medium and slow AHPs recorded in CA1 pyramidal neurons from 136 
slices maintained in short-term organotypic culture were comparable with those reported in 137 
CA1 neurons from acute hippocampal slice preparations taken from similar aged animals 138 
(Maccaferri et al., 1993; Stocker et al., 1999; Lancaster et al., 2001; Kaczorowski et al., 139 
2007; Kaczorowski, 2011).   140 
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 141 
Electrophysiology.  Slices were continuously perfused (2-3 ml/min) with aCSF supplemented 142 
with NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) (10 µM) to 143 
inhibit spontaneous AMPA receptor-mediated excitatory post-synaptic currents.  The aCSF 144 
was continuously oxygenated and temperature was maintained at ~33˚C using an HPT-2 145 
inline heater (Scientifica, UK).  Whole-cell current-clamp recordings were made from visually 146 
identified pyramidal neurones from the CA1 region of the hippocampus using an infrared-147 
light emitting diode mounted on an Axioskop2 microscope (Carl Zeiss).  Fire-polished 148 
electrodes (3-5 MΩ) were fabricated from borosilicate glass (1.5 mm O.D., 0.86 mm I.D.) 149 
containing (in mM): 125 KMeSO4, 10 KCl, 10 NaCl, 20 HEPES, 2 MgATP, 0.3 Na2GTP, 0.2 150 
EGTA, pH 7.3, osmolarity 280-285 mOsm.  A liquid junction potential error was 151 
experimentally measured (+13 mV) and was compensated for during recording.  The 152 
membrane voltage for all recordings was recorded in the bridge-balance mode of the 153 
MultiClamp 700A amplifier (Molecular Devices, CA, USA).  Voltage responses were filtered 154 
at 1.2 kHz (eight-pole low-pass Bessel filter) and sampled at 5 kHz using Pulse (HEKA 155 
Electronics, Lambrecht, Germany).   156 
 157 
Data analysis.  AHPs were elicited by evoking a train of 15 action potentials by brief (2 ms) 2 158 
nA somatic current injections delivered at 50 Hz.  Any cell that did not fire the correct number 159 
of APs was discarded.  Analysis of the medium AHP and slow AHPs were carried out using 160 
custom-written MatLab scripts (The MathWorks Company).  The mAHP were measured as 161 
the peak negative membrane deflection between 0 to 100 ms after the cessation of the last 162 
AP action potential fired.  The slow AHP was measured 1 second after the last AP action 163 
potential was fired.  The overlapping kinetic profiles of the medium AHP and slow AHP was 164 
minimized by measuring the AHP components within these time points.  Finally, the 165 
hyperpolarization induced H-current-mediated depolarizing sag was measured as the 166 
percentage difference between the peak negative deflection and the membrane voltage 167 
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once at steady state in response to a hyperpolarizing current injection (100 pA amplitude, 168 
500 ms duration) (Tamagnini et al., 2015). 169 
 170 
Cell input resistance was determined from a -100 pA current pulse (500 ms) delivered 1 171 
second before a train of action potentials to generate AHPs.  The non-conductive anion 172 
methylsulphate (MeSO4) is associated with a time-dependent rise in input resistance (Zhang 173 
et al., 1994; Velumian et al., 1997; Kaczorowski et al., 2007).  We observed that the cell 174 
input resistance rose by 13.4 ± 4.3% during a 5-minute baseline recording period (105.8 ± 175 
5.2 vs 121.0 ± 12.9 MΩ; n = 6; t = -3.0, P = 0.03; paired two-tailed Student’s t-test).  During 176 
this same 5-minute baseline recording, the medium AHP amplitude did not change (-4.4 ± 177 
0.3 vs -4.5 ± 0.2 mV; t = 0.2, P = 0.84, paired two-tailed Student’s t-test), while the slow AHP 178 
increased by 25.3 ± 21.6% (-2.2 ± 0.2 vs -2.6 ± 0.2 mV; t(5) = 1.0, P = 0.4).  All recordings 179 
used cells with a stable resting membrane potential more negative than -60 mV. 180 
 181 
Drugs.  All salts were purchased from Sigma-Aldrich except HEPES, which was obtained 182 
from Merck Serono (Fletham, UK).  Isoproterenol and propranolol were purchased from 183 
Sigma-Aldrich, whereas NBQX, ZD7288, XE991, BRL37344, SR58611A and apamin were 184 
purchased from Tocris Biosciences (Bristol, UK).  NBQX and ZD7288 were both prepared as 185 
stock solutions in dimethylsulfoxide (DMSO) and diluted in aCSF when required.  BRL37344, 186 
SR58611A, apamin, isoproterenol and propranolol were prepared as stock solutions in 187 
water.  All drugs were prepared as 1000x stock solutions and stored at -20 ˚C until required, 188 
except for isoproterenol and propranolol which were prepared daily.  All drugs were applied 189 
to the perfusion system. 190 
   191 
Statistics.  Statistical analysis was performed using SPSS (v21, IBM) and representative 192 
traces were drawn using Origin 9 (Microcal Software).  All data is presented as mean ± 193 
SEM.  Paired two-tailed Student’s t-tests were used to compare the means between control 194 
and drug treatment groups.  A repeated measures ANOVA was used to compare AHP 195 
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amplitudes after the addition of two or more drugs.  Fisher’s least significant difference (LSD) 196 
post-hoc tests were performed to assess between-drug treatment differences.   197 
  198 
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Results 199 
The β-adrenergic receptor agonist isoproterenol inhibits both the medium and slow 200 
AHPs 201 
AHPs were evoked from a membrane potential of -75 mV by a train of 15 action potentials 202 
evoked by brief (2 ms) current injections (2 nA) fired at 50 Hz (Fig.  1A).  As previously 203 
reported (Pedarzani and Storm, 1993), bath application of the selective β-adrenergic 204 
receptor agonist isoproterenol (1 µM; n = 7) reduced the amplitude of the slow AHP by 71.6 205 
± 20.6% (Fig.  1A, D & F) (-1.1 ± 0.2 vs 0.4 ± 0.2; t = -3.8, P = 0.009, paired two-tailed 206 
Student’s t-test).  We are the first to report that activation of β-adrenergic receptors also 207 
reduced the amplitude of the medium AHP, with the peak medium AHP amplitude being 208 
reduced by 37.6 ± 6.5% (Fig.  1A-B, C & E) (-3.1 ± 0.4 vs -1.9 ± 0.3 mV; t = -4.6, P = 0.004, 209 
paired two-tailed Student’s t-test).  Both responses were antagonised by the selective 210 
competitive β-adrenergic receptor antagonist, propranolol.  Pre-treatment of slices with 211 
propranolol (10 µM) for 10 minutes prevented the effect of isoproterenol in suppressing 212 
either the medium (Fig.  1G) (control -5.2 ± 1.3 mV, propranolol -5.6 ± 1.7 mV, propranolol + 213 
isoproterenol -5.4 ± 1.8 mV; overall effect of drugs F(2, 6) = 0.2, P = 0.81, repeated measures 214 
ANOVA) or slow (Fig.  1H) (control -3.6 ± 1.5 mV, propranolol -4.1 ± 1.8 mV, propranolol + 215 
isoproterenol -4.4 ± 2.0 mV; n = 4; overall effect of drugs F(2,6) = 1.4, P = 0.33, repeated 216 
measures ANOVA) AHPs.  These data indicate that activation of β-adrenergic receptors 217 
suppresses both the medium and slow AHPs. 218 
 219 
β-adrenergic receptor-mediated modulation of the medium AHP is independent of a 220 
rise of intracellular cAMP 221 
The time-course of the medium and slow AHPs overlap (Stocker et al., 1999; Gerlach et al., 222 
2004), making it difficult to resolve whether each AHP component can be modulated 223 
independently.  The slow AHP was suppressed by inclusion of cAMP (1 mM) in the whole-224 
cell electrode solution (Pedarzani and Storm, 1993) (non-cAMP, n = 80, cAMP, n = 20; 225 
overall effect of cAMP F(1, 98) = 13.4, P = 0.0004; two-way repeated measures ANOVA. Fig. 226 
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2A), and was observed together with a significant reduction in the amplitude of the medium 227 
AHP (Fig.  2B) (n = 80, cAMP, n = 20; overall effect of cAMP F(1, 98) = 12.6, P = 0.0006; two-228 
way repeated measures ANOVA).  It is most likely that these observations reflect an overlap 229 
in time-course.  Therefore, it is crucial to determine whether the medium AHP is sensitive to 230 
isoproterenol in neurons dialyzed with cAMP.  Addition of isoproterenol (1 µM) to neurons 231 
dialyzed with cAMP (1 mM) reduced the amplitude of the medium AHP by 58.2 ± 8.2% (Fig.  232 
2C, D, E & F) (-1.9 ± 0.3 vs -0.9 ± 0.3 mV; n = 5; t = -8, P = 0.001, paired two-tailed 233 
Student’s t-test).  The magnitude of reduction of the mAHP by isoproterenol was the same 234 
between control and cells dialyzed with cAMP (t = 1.9, p = 0.073).  These data demonstrate 235 
that suppression of the medium AHP by isoproterenol is not the result of an overlapping 236 
time-course of afterpotentials and suppression of the slow AHP.  It is apparent that the effect 237 
of isoproterenol is mediated by β-adrenergic receptors and that suppression of the medium 238 
AHP is independent of a rise of intracellular cAMP.   239 
 240 
Blocking HCN channels with ZD7288 reduced suppression of the medium AHP by 241 
isoproterenol 242 
The medium AHP in hippocampal CA1 pyramidal neurons is proposed to be mediated by 243 
activation of SK and deactivation of HCN channels at hyperpolarized voltages (Gu et al., 244 
2005; Kaczorowski, 2011; Church et al., 2015).  This was confirmed by observing that 245 
addition of the HCN channel blocker ZD7288 (1 µM) blocked the medium AHP by 52.2 ± 246 
16.5% (P = 0.047) (Fig. 3A-D), with the sequential addition of the SK channel inhibitor 247 
apamin (100 nM) blocking the remaining afterpotential by a further 43.3 ± 11.8% (P = 0.054) 248 
(Fig.  3A-D) (control -4.3 ± 1.5 mV, ZD7288 -2.0 ± 0.7 mV, ZD7288 + apamin -0.1 ± 0.3 mV; 249 
n = 4; overall effect of drugs F(2, 6) = 19.8, P = 0.002, repeated measures ANOVA).  No effect 250 
of either ZD7288 or apamin on the slow AHP was observed (Fig.  3D) (control -1.8 ± 0.1 mV, 251 
ZD7288 -2.4 ± 0.2 mV, ZD7288 + apamin -2.2 ± 0.4 mV; n = 4; overall effect of drugs F(2, 6) = 252 
1.9, P = 0.23, repeated measures ANOVA). 253 
 254 
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These data pose the question of which channel subtype(s) is modulated by β-adrenergic 255 
receptor activation.  Blocking HCN channels with ZD7288 (1 μM) reduced the medium AHP 256 
by 74.5 ± 14.5% (P =  0.06) (Fig. 4Ai-iv) and reduced the effect of subsequent concomitant 257 
addition of isoproterenol (1 μM) (Fig. 4Ai-iv) (control -4.4 ± 0.5 mV, ZD7288 -1.0 ± 0.5 mV, 258 
ZD7288 + isoproterenol -0.8 ± 0.6 mV; n = 3; overall effect of drugs F(2, 4) = 15.1, P = 0.014; 259 
main effect of ZD7288 P = 0.06; main effect of ZD7288 + isoproterenol P = 0.21; repeated 260 
measures ANOVA).  In contrast, application of apamin (100 nM) blocked the medium AHP 261 
by 32.7 ± 6.3% (P = 0.007) (Fig. 4Bi-iv), with the concomitant addition of isoproterenol (1 262 
μM) still suppressing the remaining medium AHP by 37.2 ± 8.4% (Fig.  4Bi-iv) (P = 0.003) 263 
(control -4.9 ± 0.8 mV; apamin -3.4 ± 0.7 mV; apamin + isoproterenol -1.5 ± 0.6 mV; n = 4; 264 
overall effect of drugs F(2, 6) = 22.8, P = 0.002; repeated measures ANOVA).  Activation of 265 
HCN channels by membrane hyperpolarization results in a depolarizing sag in the 266 
electrotonic potential.  This sag is reduced by HCN channel blockers, such as ZD7288 (Day 267 
et al., 2005; Thuault et al., 2013).  Application of a sub-maximal concentration of ZD7288 (1 268 
μM) reduced the sag by 96%, reducing the sag from contributing 29.6 ± 2.1% of the 269 
electrotonic potential to contributing 2.1 ± 1.2% (t = 13.8; p < 0.0001, paired two-tailed 270 
Student’s t-test).  Application of isoproterenol (1 μM) resulted in a 27.6 ± 8.8% reduction in 271 
depolarizing sag (25.6 ± 1 vs 18.6 ± 2.4%; n = 7; t = 3.3 P = 0.02; paired two-tailed Student’s 272 
t-test).  These data strongly suggest that suppression of the medium AHP by isoproterenol is 273 
mediated by modulating HCN channel activity in hippocampal CA1 pyramidal neurons. 274 
 275 
The selective β3-adrenergic receptor agonists BRL37344 and SR58611A suppress the 276 
medium AHP 277 
Low levels of β3-adrenergic receptor mRNA is expressed in the hippocampus of mouse and 278 
rat (Evans et al., 1996; Claustre et al., 2008).  β3-adrenergic receptors display a low binding 279 
affinity for propranolol (Hoffmann et al., 2004), and we observed that pre-treating 280 
hippocampal slices with 1 µM propranolol (n = 8) failed to antagonise the effect of 281 
isoproterenol on the medium AHP (data not shown).  The β3-adrenergic receptor selective 282 
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agonist BRL37344 (10 µM; n = 4) (Hoffmann et al., 2004) suppressed the medium AHP by 283 
42.2 ± 9.3% (Fig.  5Ai-ii) (-3 ± 0.4 vs -1.8 ± 0.5 mV; t = -4.2, P = 0.025, paired two-tailed 284 
Student’s t-test).  Application of a second β3-adrenergic receptor selective agonist 285 
SR58611A (10 µM) (Bianchetti and Manara, 1990; Simiand et al., 1992) also suppressed the 286 
medium AHP by 33.7 ± 6.5% (Fig.  5Bi-ii) (-3.1 ± 0.4 vs -2.1 ± 0.4 mV; n = 7; t = -3.6, P = 287 
0.012).  The magnitude of suppression of the medium AHP by BRL37344 and SR58611A 288 
were not significantly different (t = -1.1, P = 0.312; unpaired two-tailed Student’s t-test).  In 289 
contrast to BRL37344 which exhibited no significant reduction on the H-current-mediated 290 
depolarizing sag (25.8 ± 2.4 vs 18.1 ± 2.6%; n = 4; t = 1.9; P = 0.151; paired two-tailed 291 
Student’s t-test), SR58611A reduced the H-current-mediated depolarizing sag by 17.5% 292 
(23.2 ± 3.0 vs 19.0 ± 2.9%; n = 10; t = 3.0; P = 0.014; paired two-tailed Student’s t-test).  293 
BRL37344 (10 µM) failed to affect the medium AHP when applied in the presence of 294 
propranolol (10 µM) (Fig. 5C & D) (control -4.7 ± 0.9 mV, propranolol -5.0 ± 1.5 mV, 295 
propranolol + BRL37344 -4.9 ± 1.6 mV; F(2,4) = 0.1, P = 0.93, repeated measures ANOVA; n 296 
= 3).  These findings indicate the presence of functional β3-adrenergic receptors in 297 
hippocampal CA1 pyramidal neurons that selectively suppress the medium AHP, and not the 298 
slow AHP.  Finally, BRL37344 (10 µM) suppressed the medium AHP by 37.8 ± 8.2% in CA1 299 
pyramidal neurons dialyzed with cAMP (1 mM) (Fig. 5E & F) (-2.9 ± 0.2 vs -1.8 ± 0.2 mV; t = 300 
-4.3, P = 0.003; n = 9, paired two-tailed Student’s t-test),  There was no significant difference 301 
in the magnitude of block produced by BRL37344 (10 μM) in cAMP-dialysed cells (1 µM) 302 
compared with non-cAMP dialysed neurons (0 mM cAMP 42.2 ± 9.3%; 1 mM cAMP 37.8 ± 303 
8.2% t = 0.3, P = 0.76).  These data confirm that activation of β3-adrenergic receptors 304 
suppresses the medium AHP by a cAMP-independent signalling pathway. 305 
  306 
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Discussion 307 
The slow AHP is unusual in being a potassium current subject to modulation by GPCR 308 
activation (Pedarzani and Storm, 1993).  This slow afterpotential is sensitive to activation of 309 
GPCRs that are coupled via Gs to activation of adenylate cyclase, a rise of intracellular 310 
cAMP and subsequent activation of protein kinase A (Pedarzani and Storm, 1993).  We have 311 
confirmed the sensitivity of the slow AHP to activation of β-adrenergic receptors and a rise of 312 
intracellular cAMP.  In contrast, evidence of the medium AHP being modulated by 313 
metabotropic receptor activation in hippocampal pyramidal cells is lacking.  It was noted that 314 
the medium AHP was reduced when the slow AHP was suppressed by forskolin, but this 315 
was suggested to result from an overlap of the time-courses of the two components of the 316 
AHP (Gu et al., 2005).  We have carefully separated the amplitudes of the two 317 
afterpotentials, by plotting of the AHP time-course on a log time base (Figure 1B).  In 318 
addition, we have presented data of the reduction of the medium AHP by isoproterenol in 319 
cells where the slow AHP has been abolished by intracellular dialysis of cAMP (Figure 2C-320 
F).  These data confirm that the medium AHP is a substrate for modulation and that 321 
suppression of the afterpotential is not mediated by a rise of intracellular cAMP.  The effect 322 
of isoproterenol was mimicked by two selective β3-adrenergic receptor agonists, BRL37344 323 
and SR58611A.  The mRNA encoding the β3-adrenergic receptor has been detected in 324 
various brain regions including the hippocampus in rat, mouse and humans (Rodriguez et 325 
al., 1995; Evans et al., 1996; Claustre et al., 2008).  The precise role of the β3-adrenergic 326 
receptor in brain is unclear, but BRL37344 and SR58611A possess anti-depressant and 327 
anxiolytic-like effects in rodents (Simiand et al., 1992; Claustre et al., 2008; Stemmelin et al., 328 
2008; Tanyeri et al., 2013).  Activation of  hippocampal β3-adrenergic receptors by 329 
norepinephrine and isoproterenol mediate an increase in hippocampal neural precursor 330 
activity by enhancing the proliferation of multipotent neuronal stem (Jhaveri et al., 2010). 331 
 332 
BRL37344 displays a 90-fold and 20-fold higher selectivity towards rat β3-adrenergic 333 
receptors compared with β1- and β2-adrenergic receptors respectively (Hoffmann et al., 334 
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2004), whereas SR58611A exhibits a 280-fold and 140-fold higher selectivity for rat β3-335 
adrenergic receptors compared with β1- and β2-adrenergic receptors respectively (Gauthier 336 
et al., 1996; Stemmelin et al., 2008).  The selectivity of these agonists is better than that 337 
reported for available β3-adrenergic receptor antagonists.  For example, L-748337 displays 338 
less than a 20-fold selectivity and L-748328 exhibits only a 45-fold selectivity for β3-339 
adrenergic receptors over β2-adrenergic receptors (Candelore et al. 1999).  In addition, SR 340 
59230A displays only a 10-fold selectivity for β3-adrenergic receptors over β1- and β2-341 
adrenergic receptors (Manara et al., 1996).   In absence of attempting full concentration-342 
response relationships in the absence and presence of increasing concentrations of 343 
antagonist(s), we elected to use β3-adrenergoic receptor-selective agonists to elucidate the 344 
role of these receptors in hippocampal neurons.  A very small reduction in the amplitude of 345 
the slow AHP was seen in the presence of BRL37344, but not when SR58611A was applied 346 
(Figure 5Aii & 5Bii), which might result from the low affinity binding of BRL37344 to β1- and 347 
β2-adrenergic receptors.  These findings indicate that activation of β3-adrenergic receptors 348 
suppresses the medium and not the slow AHP in hippocampal CA1 pyramidal neurons. 349 
 350 
SK and HCN channels underlie the medium AHP in CA1 pyramidal neurons at 351 
hyperpolarized potentials 352 
There is some controversy regarding the channel subtypes that contribute to the medium 353 
AHP, with activation of SK (Stocker et al. 1999) and deactivation of HCN channels (Gu et al. 354 
2005) being proposed to underlie the afterpotential at hyperpolarized potentials.  The role of 355 
SK channel activation is unclear, as it has been suggested only to result from non-356 
physiological activation protocols used in voltage clamp (Gu et al. 2005).  The data 357 
presented in this study shows that the HCN channel blocker ZD7288 (1 μM) reduced the 358 
medium AHP by 55-75% in neurons held at -75 mV, confirming deactivation of HCN channel 359 
current is a significant component of the medium AHP (Gu et al., 2005; Kaczorowski, 2011).  360 
Apamin (100 nM) blocked the medium AHP remaining in ZD7288 (1 μM), confirming that SK 361 
channel activation mediates a significant component of the medium AHP (Stocker et al., 362 
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1999; Bond et al., 2004; Kaczorowski et al., 2007; Church et al., 2014).  Both SK and HCN 363 
channels can be either homomeric or heteromeric.  For example, the current underlying the 364 
medium AHP is inhibited by apamin with an IC50 of 450 pM (Stocker et al., 1999), which is 365 
reminiscent of the sensitivity of heteromeric SK1-SK2 channel current to the toxin (Church et 366 
al. 2015).  Homo- and hetero-tetrameric HCN channels display different electrophysiological 367 
and kinetic properties when expressed in heterologous cell lines (Santoro et al., 2000; 368 
Robinson and Siegelbaum, 2003; Wahl-Schott and Biel, 2009).  The expression of HCN 369 
channel subunits varies throughout the brain, with only HCN1 and HCN2 mRNA and protein 370 
abundantly expressed in the hippocampus (Santoro et al., 2000). Native H-current is thought 371 
to be mediated by a population of heteromeric HCN1-2 and homomeric HCN1 subunit 372 
channels because the biophysical properties of H-current recorded in CA1 pyramidal reflect 373 
a population of heteromeric HCN1-2 channels and possible HCN1 homomeric channels 374 
(Santoro et al. 2000). 375 
 376 
Non-selective actions of ZD7288 have been reported, with T-type calcium channel current 377 
blocked with an IC50 of 100 μM (Felix et al., 2003), ionotropic glutamate receptor currents 378 
reduced by 40% using 20 μM ZD7288 (Chen, 2004), and inhibition of sodium channel 379 
current in dorsal root ganglion neurons with an IC50 close to 10 μM (Wu et al., 2012).  In 380 
addition, relatively long-term application of ZD7288 can produce non-selective effects, with 381 
application of ZD7288 (30 μM) producing a significant depression of glutamatergic-mediated 382 
synaptic activity at hippocampal mossy fibre synapses (Chevaleyre and Castillo, 2002; Gill et 383 
al., 2006).  We circumvented the possibility of non-selective effects of ZD7288 by blocking 384 
AMPA receptor-mediated synaptic potentials with NBQX, using only 1 μM of the compound, 385 
and finally recording the effect of the HCN channel blocker within 10 minutes of application.  386 
Pre-block of HCN channels with ZD7288 reduced suppression of the remaining medium 387 
AHP by isoproterenol (Fig. 4Aiii & iv).  These data suggest that β3-adrenergic receptor-388 
mediated suppression of the medium AHP occurs by inhibition of HCN channel activity.  389 
HCN channel activation undergoes a depolarizing shift from an increase in the intracellular 390 
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cAMP concentration (Wainger et al., 2001; Santoro et al., 2004; Chen et al., 2007; Zong et 391 
al., 2012).  However, activation of β3-adrenergic receptors suppresses the medium AHP in 392 
neurons dialyzed with cAMP.  These data show that modulation of HCN channels is 393 
independent of a rise of intracellular cAMP. 394 
 395 
Do β3ARs functionally couple with HCN channels? 396 
The medium AHP was retained in cells dialyzed with cAMP.  Furthermore, the reduction of 397 
the medium AHP by isoproterenol was independent of intracellular cAMP levels.  In addition, 398 
the medium AHP was reduced in amplitude by the β3 adrenergic receptor-selective agonist 399 
BRL37344, both in control cells and cells dialyzed with cAMP.  The isoproterenol- and 400 
BRL37344-mediated suppression of the medium AHP in the presence of raised intracellular 401 
cAMP indicates that the inhibitory effect on the medium AHP is not mediated by activation of 402 
either Gαs- or Gαi G-protein affecting cAMP levels.  The β3-adrenergic receptor signalling 403 
pathway is ill-defined, with the receptor being reported to couple to Gαs or Gαi (Collins, 404 
2012).  Other studies report β3-adrenergic receptors signal in a biphasic manner by coupling 405 
to both Gαs and Gαi (Begin-heick, 1995; Gauthier et al., 1996; Hadi et al., 2013).  406 
Regardless of possible second messenger pathways, activation of β3-adrenergic receptors 407 
causes relaxation of rat bladder, an effect blocked by ZD7288.  This observation indicates 408 
that coupling can occur between activation of β3-adrenergic receptors and HCN channels 409 
(Kashyap et al., 2015).  The reported anti-depressant and anti-anxiolytic properties of β3-410 
adrenergic receptor agonists make this pathway an attractive one to target, with further 411 
investigation being needed.  412 
 413 
HCN channels, which underlie H-current, are a key regulator of intrinsic excitability in CA1 414 
pyramidal neurons.  H-current has a direct influence on neuronal input resistance, the resting 415 
membrane potential and membrane time constant.  H-current filters out low frequency 416 
fluctuations in membrane voltage in a self-regulating feedback mechanism to regulate 417 
synaptic input (He et al., 2014).  Inhibition of H-current by ZD7288 increased firing frequency 418 
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in hippocampal neurons (Gasparini & DiFrancesco, 1997), an effect demonstrating the 419 
contribution of the H-current to the medium AHP.  It is interesting to note that this current can 420 
be modulated to affect firing by activation of a receptor that is expressed at low levels in 421 
hippocampal neurons.  It will be useful to resolve the relative subcellular locations of HCN 422 
and β3-adrenergic receptors in hippocampal neurons to determine if coupling is localized 423 
within the cell. 424 
 425 
Afterhyperpolarizations have a profound impact on hippocampal neuronal excitability.  Action 426 
potential firing frequency increases with inhibition of either the medium (Stocker et al., 1999) 427 
or the slow AHP (Madison and Nicoll, 1982, 1986; Pedarzani and Storm, 1993; Pedarzani et 428 
al., 1998; Stocker et al., 1999).  The amplitude of the AHP is correlated with learning and 429 
memory with larger AHPs being observed in aged animals that have difficulty in learning.  430 
Pharmacological suppression of the AHP in aged animals improves learning of a simple 431 
associative task (Moyer and Disterhoft, 1994; Tombaugh et al., 2005).  The identification of a 432 
novel mechanism regulating the medium AHP provides additional plasticity to how 433 
membrane excitability might change to affect these processes.  The identity of functional β3-434 
adrenergic receptors in hippocampal CA1 neurons highlights a potential new target in 435 
modulating HCN channels and thereby synaptic plasticity. 436 
  437 
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Figure 1. Isoproterenol suppresses the medium and slow AHPs in hippocampal CA1 668 
pyramidal neurons. 669 
A. Representative membrane voltage traces of the AHP evoked by 15 action potentials 670 
elicited by 2 ms current injections delivered at 50 Hz before (control, black) and after the 671 
addition of isoproterenol (1 µM; grey). The action potentials are truncated for clarity. 672 
B.  Evoked medium (mAHP) and slow afterhyperpolarizations (sAHP) plotted on a log10 time 673 
scale to illustrate how the mAHP and sAHP were discriminated.  The mAHP amplitude was 674 
measured from the peak voltage deflection recorded at 0-100 ms post-burst, and the sAHP 675 
amplitude was measured as the amplitude at 1 s post-burst. 676 
C.  Diary plot of the amplitude of the medium AHP.  Application of isoproterenol (1μM) 677 
reduced the amplitude of the evoked medium AHP (n=7). 678 
D.  Diary plot of the amplitude of the slow AHP.  Application of isoproterenol (1μM) largely 679 
abolished the amplitude of the evoked slow AHP (n=7). 680 
Bar charts depicting the reduction in the amplitudes of the evoked medium (mAHP) (E) and 681 
slow (sAHP) AHPs (F) amplitude by isoproterenol (1 μM).  (n=7, paired two-way Student’s t-682 
test, ** P < 0.01). 683 
Bar charts depicting the lack of effect on the amplitudes of the evoked medium (mAHP) (G) 684 
and slow (sAHP) AHPs (H) amplitude by isoproterenol (1 μM), when applied in the presence 685 
of propranolol (10 μM) (n=4, repeated measures ANOVA, NS P > 0.05). 686 
 687 
 688 
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Figure 2.  Suppression of the medium AHP by isoproterenol in cells dialysed with 689 
cAMP. 690 
A.  Bar chart showing the amplitude of the slow AHP (sAHP) in control cells (black bars, 691 
n=80) and in cells dialysed with cAMP (1 mM) (hollow bars, n=20).  The slow AHP was 692 
measured after being evoked by 5 to 25 action potentials, with the amplitude of the slow 693 
afterpotential increasing with increasing number of action potentials.  The slow AHP was 694 
occluded in cells dialysed with cAMP (1 mM).  695 
B.  Bar chart showing that dialysis with cAMP (1 mM) (n=20) reduces the amplitude but does 696 
not occlude the medium AHP.  The medium AHP was measured after being evoked by 5 to 697 
25 action potentials, with the amplitude of the medium AHP increasing with increasing 698 
number of action potentials in control (black bars, n=80) and in the presence of intracellular 699 
cAMP (hollow bars, n=20).   700 
C.  Effect of isoproterenol (1 µM; grey) on the medium AHP evoked by 15 APs fired at 50 701 
Hz.  Note the lack of a slow AHP in both control (black) and in the presence of isoproterenol.  702 
Action potentials have been truncated for clarity. 703 
D.  Evoked medium (mAHP) displayed on a log10 time scale, showing the lack of a slow 704 
AHP.  Application of isoproterenol (1 μM) supressed the medium AHP (grey trace). 705 
E.  Diary plot of the amplitude of the medium AHP.  Application of isoproterenol (1μM) 706 
suppressed the medium AHP amplitude in cells dialysed with cAMP (1 mM) (n=5). 707 
F.  Bar chart showing the amplitude of the medium AHP in control (black bar) and in the 708 
presence of isoproterenol (1 μM) (hollow bar).  Isoprotenerol (1 μM) suppressed the medium 709 
AHP in cells dialyzed with cAMP (n=5, paired two-way Student’s t-test, *** P < 0.001). 710 
 711 
 712 
Figure 3.  SK and HCN channels mediate the medium AHP in hippocampal CA1 713 
pyramidal neurons held at -75 mV. 714 
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A.  Representative membrane voltage traces of AHPs evoked by a train of 15 action 715 
potentials fired at 50 Hz in control conditions (black), ZD7288 (1 µM; dark grey), and apamin 716 
(100 nm) + ZD7288 (1 μM, light grey). Action potentials have been truncated for clarity. 717 
B.  Evoked medium AHP and slow AHP from A displayed on a log10 time scale to illustrate 718 
the complete block on the medium AHP following the sequential inhibition of HCN and SK 719 
channels by ZD7288 and apamin, respectively. 720 
C.  Diary plot of the amplitude of the medium AHP before and after the sequential addition of 721 
ZD7288 (1 μM) and ZD7288 + apamin (100 nM).  Note that the medium AHP is completely 722 
inhibited by the combination of channel blockers. 723 
D.  Bar chart illustrating the reduction of the medium AHP by ZD7288 (1 μM), and ZD7288 + 724 
apamin (100 nM), with no effect of either blocker on the amplitude of the slow AHP. 725 
 726 
 727 
Figure 4.  Block of HCN channels reduces suppression of the medium AHP by 728 
isoproterenol. 729 
Ai,  Representative membrane voltage trace of the AHP evoked by a train of 15 action 730 
potentials fired at 50 Hz in the absence (black trace) and presence of the H-current blocker 731 
ZD7288 (1 μM, dark grey), and ZD7288 + isoprotenerol (1 μM, light grey).  The medium AHP 732 
was largely blocked by ZD7288, with the addition of isoproterenol having little effect. 733 
Aii.  Evoked medium (mAHP) and slow (sAHP) AHPs displayed on a log10 time scale, 734 
showing the large block of the medium AHP by ZD7288 (dark grey) occluding subsequent 735 
suppression by isoproterenol (light grey). 736 
Aiii.  Diary plot of the amplitude of the medium AHP, showing the dominating effect of block 737 
of H-current by ZD7288 (1 μM) and minor effect of subsequent addition of isoproterenol (1 738 
μM). 739 
Aiv.  Bar chart showing the amplitude of the medium AHP, significant block of that amplitude 740 
by ZD7288 and minor additional effect of the subsequent addition of isoprotenerol. 741 
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Bi.  Representative membrane voltage trace of the AHP evoked by a train of 15 action 742 
potentials fired at 50 Hz in the absence (black trace) and presence of the SK channel 743 
inhibitor apamin (100 nM, dark grey), and apamin + isoprotenerol (1 μM, light grey).   Only a 744 
small effect of apamin on the medium AHP was observed, with subsequent addition of 745 
isoproterenol significantly suppressing both the medium and slow AHPs. 746 
Bii.  Evoked medium (mAHP) and slow (sAHP) AHPs displayed on a log10 time scale, 747 
showing the minor block of the medium AHP by apamin (dark grey), with a much greater 748 
suppression of both the medium and slow AHPs by subsequent addition of isoproterenol 749 
(light grey). 750 
Biii.  Diary plot of the amplitude of the medium AHP, showing the minor block by apamin 751 
(100 nM) and the significant suppression produced by the subsequent addition of 752 
isoproterenol (1 μM). 753 
Biv.  Bar chart showing the amplitude of the medium AHP.  Addition of apamin (100 nM) 754 
blocked only a small component of the medium AHP, with a much greater suppression 755 
observed on the subsequent addition of isoprotenerol. 756 
 757 
 758 
Figure 5.  β3 adrenergic receptor activation suppresses the medium AHP. 759 
Ai.  Representative membrane voltage trace of AHPs evoked by a train of 15 action 760 
potentials fired at 50 Hz in the absence (black) and presence of the β3AR selective agonist 761 
BLR37344 (10 µM; grey). 762 
Aii.  Evoked medium AHP and slow AHP from Ai displayed on a log10 time scale to illustrate 763 
a reduction in the medium and slow AHPs by addition of BRL37344 (10 μM). 764 
Aiii.  Bar chart showing suppression of both AHP components by BRL37344 (10 μM) (n=4; 765 
paired two-tailed Student’s t-test). 766 
Bi.  Representative membrane voltage trace of AHPs evoked by a train of 15 action 767 
potentials fired at 50 Hz in the absence (black) and presence of the β3AR selective agonist 768 
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SR58611A (10 µM; grey) in CA1 pyramidal neurons. Action potentials were truncated for 769 
clarity.  770 
Bii.  Evoked medium AHP and slow AHP from Bi displayed on a log10 time scale to illustrate 771 
a reduction in the medium AHP by addition of SR58611A (10 μM).  Note the lack of effect of 772 
the β3-adrenergic receptor agonist on the slow AHP (see Discussion). 773 
Biii.  Bar chart showing suppression of both AHP components by SR58611ABRL37344 (10 774 
μM) (n=7; paired two-tailed Student’s t-test). 775 
C.  Diary plot of the amplitude of the medium AHP and the lack of effect of addition of 776 
BRL37344 (10 μM) in the continued presence of propranolol (10 μM). 777 
D.  Bar chart showing the amplitude of the medium AHP in control conditions, after 10 778 
minute incubation with propranolol (10 μM), and after addition of BRL37344 (10 μM) in the 779 
continued presence of propranolol. 780 
E.  Evoked mAHP and sAHP plotted on a log10 time scale from a cell dialyzed with cAMP (1 781 
mM)(black trace).  Addition of BRL37344 (10 μM) suppressed the mAHP in cAMP-dialyzed 782 
cells (grey trace). 783 
F.  Summary bar chart showing small but robust block of the mAHP by BRL37344 (10 μM) 784 
(n = 9, paired two-tailed Student’s t-test). 785 
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